Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Medium-sized particles penetrate hair follicles better than smaller or larger ones, which could improve delivery of skin treatments.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Mutant mice help researchers understand hair growth and related genetic factors.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Maintaining the right amount of retinoic acid is crucial for healthy hair and skin.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.